Biogena Group Invest AG (WBO:BIO) Equity-to-Asset : 0.96 (As of Jan. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Biogena Group Invest AG Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Biogena Group Invest AG's Total Stockholders Equity for the quarter that ended in Jan. 2024 was €8.49 Mil. Biogena Group Invest AG's Total Assets for the quarter that ended in Jan. 2024 was €8.86 Mil. Therefore, Biogena Group Invest AG's Equity to Asset Ratio for the quarter that ended in Jan. 2024 was 0.96.

The historical rank and industry rank for Biogena Group Invest AG's Equity-to-Asset or its related term are showing as below:

WBO:BIO' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.95 Med: 0.97 Max: 0.99
Current: 0.96

During the past 4 years, the highest Equity to Asset Ratio of Biogena Group Invest AG was 0.99. The lowest was 0.95. And the median was 0.97.

WBO:BIO's Equity-to-Asset is ranked better than
98.55% of 1926 companies
in the Consumer Packaged Goods industry
Industry Median: 0.54 vs WBO:BIO: 0.96

Biogena Group Invest AG Equity-to-Asset Historical Data

The historical data trend for Biogena Group Invest AG's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogena Group Invest AG Equity-to-Asset Chart

Biogena Group Invest AG Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

Equity-to-Asset

0.95

0.99

0.98

0.96

Biogena Group Invest AG Semi-Annual Data
	Jan21	Jan22	Jan23	Jan24
Equity-to-Asset	0.95	0.99	0.98	0.96

Competitive Comparison of Biogena Group Invest AG's Equity-to-Asset

For the Packaged Foods subindustry, Biogena Group Invest AG's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biogena Group Invest AG's Equity-to-Asset Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Biogena Group Invest AG's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Biogena Group Invest AG's Equity-to-Asset falls into.

Biogena Group Invest AG Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Biogena Group Invest AG's Equity to Asset Ratio for the fiscal year that ended in Jan. 2024 is calculated as

Equity to Asset (A: Jan. 2024 )	=	Total Stockholders Equity	/	Total Assets
	=	8.493	/	8.859
	=	0.96

Biogena Group Invest AG's Equity to Asset Ratio for the quarter that ended in Jan. 2024 is calculated as

Equity to Asset (Q: Jan. 2024 )	=	Total Stockholders Equity	/	Total Assets
	=	8.493	/	8.859
	=	0.96

Biogena Group Invest AG (WBO:BIO) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Biogena Group Invest AG Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Biogena Group Invest AG's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Biogena Group Invest AG (WBO:BIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biogena Group Invest AG (WBO:BIO) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Strubergasse 24, Salzburg, AUT, 5020

Website

https://www.biogenagroup.com

Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.